Peter C. Richardson

Insider Reports History

Entity
Individual
Location
28903 North Avenue Paine, Valencia, CA
Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter C. Richardson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mallinckrodt plc EVP & Chief Scientific Officer Restricted Stock Units 10.3K Feb 2, 2024 Direct
ANTARES PHARMA, INC. EVP, Research and Development and Chief Medical Officer Common Stock 0 $5.60 May 24, 2022 Direct
ANTARES PHARMA, INC. EVP, Research and Development and Chief Medical Officer Stock Option (right to buy) 0 May 24, 2022 Direct
Mallinckrodt plc EVP & Chief Scientific Officer Ordinary Shares 0 $37.50 Nov 14, 2023 Direct

Insider Reports Filed by Peter C. Richardson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NONE Mallinckrodt plc Feb 2, 2024 1 $0 4 Feb 6, 2024 EVP & Chief Scientific Officer
MNKTQ Mallinckrodt plc Nov 14, 2023 1 $0 4 Nov 16, 2023 EVP & Chief Scientific Officer
MNKTQ Mallinckrodt plc Jun 30, 2023 1 $0 4 Jul 5, 2023 EVP & Chief Scientific Officer
MNKTQ Mallinckrodt plc Apr 3, 2023 1 $0 4 Apr 5, 2023 EVP & Chief Scientific Officer
MNKTQ Mallinckrodt plc Feb 2, 2023 1 $0 4 Feb 3, 2023 EVP & Chief Scientific Officer
MNKTQ Mallinckrodt plc Jan 12, 2023 0 $0 3 Jan 20, 2023 EVP & Chief Scientific Officer
ATRS ANTARES PHARMA, INC. May 24, 2022 4 -$283K 4 May 26, 2022 EVP, Research and Development and Chief Medical Officer
ATRS ANTARES PHARMA, INC. Jun 10, 2021 2 $160K 4 Jun 14, 2021 EVP, R&D Chief Medical Officer